In this article, we are going to take a look at where Corcept Therapeutics Incorporated (NASDAQ:CORT) stands against the other best performing pharma stocks so far in 2025. On February 20 ...

REDWOOD CITY, Calif., March 10, 2025--Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe ...

Check Out Our Latest Stock Report on CORT Corcept Therapeutics Stock Performance Shares of Corcept Therapeutics stock opened at $70.15 on Wednesday. The company has a quick ratio of 3.64, a ...

The National Chairman of the Labour Party, Julius Abure on Sunday said he has no regret zoning the presidential ticket of LP again to the South-East ahead of the 2027 election. Abure also pledged ...

Finally, Two Sigma Advisers LP grew its stake in shares of Easterly Government Properties by 303.8% in the 4th quarter. Two Sigma Advisers LP now owns 428,000 shares of the real estate investment ...

Axsome Therapeutics, Inc. (NASDAQ:AXSM) is a commercial-stage biopharmaceutical company that develops and delivers therapies for central nervous system (CNS) conditions with limited treatment ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Final results of the OCEAN(a)-DOSE trial – published in the New England Journal of Medicine – showed that the small, interfering RNA (siRNA) drug reduced Lp(a) levels compared to placebo at ...

Lipoprotein(a), or Lp(a), is a protein that transports cholesterol in the blood. High levels of Lp(a) in the blood can increase the likelihood of plaques or blood clots forming in the arteries.